|
Index of reports
> Cases with Dyspnoea (135)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 135 Next >>
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-08-23
Patient:
Reactions: Back Pain, Electrocardiogram QT Prolonged, Dyspnoea, Hypotension, Thrombocytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
JNJ-26481585
Dosage: 12 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-05-31
Velcade
Dosage: 2.1 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Acetaminophen; Zelitrex / 01269701 /; Fentanyl; Atracurium Besylate; Kardegic / 00002703 /; Oxycontin; Oxygen; Tranxene; Primperan / 00041901 /; Bumetanide; Crestor; Primperan / 00041901 /; Hydrocortisone; Ondansetron; Ondansetron; Ondansetron; Importal; Tramadol HCL; Noradrenaline / 00127501 /; Tramadol HCL; Morphine; Furosemide; Midazolam; Tramadol HCL
Possible Dexamethasone side effects in female
Reported by a physician from France on 2012-08-21
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.82 milligram daily;
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Dexamethasone
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Rituximab
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Treanda
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Other drugs received by patient: Pegfilgrastim
Possible Dexamethasone side effects in female
Reported by a physician from France on 2012-08-21
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.82 milligram daily;
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Dexamethasone
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Rituximab
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Treanda
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Other drugs received by patient: Pegfilgrastim
Possible Dexamethasone side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: 68 year old female, weighing 88.0 kg (193.6 pounds)
Reactions: Dyspnoea, Pneumonia, Urinary Tract Infection, Constipation, Disease Progression, Multi-Organ Failure, Hypothyroidism, Gastrooesophageal Reflux Disease, Candidiasis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Crizotinib
Dosage: 500 mg
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2011-07-26
End date: 2011-08-16
Dexamethasone
Dosage: 8 mg
Administration route: Oral
Indication: Palliative Care
Start date: 2011-07-05
Other drugs received by patient: Calcium; Vicoprofen; Levothyroxine Sodium; Prochlorperazine; Omeprazole; Albuterol; Oxycontin; Ondansetron; Lactulose; Folic Acid; Atorvastatin; Colace; Clonazepam
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-08-16
Patient:
Reactions: Electrocardiogram QT Prolonged, Back Pain, Dyspnoea, Hypotension, Thrombocytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
JNJ-26481585
Dosage: 12 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-05-31
Velcade
Dosage: 2.1 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Bumetanide; Acetaminophen; Morphine; Atracurium Besylate; Ondansetron; Crestor; Fentanyl; Furosemide; Midazolam; Tranxene; Ondansetron; Tramadol HCL; Noradrenaline / 00127501 /; Hydrocortisone; Importal; Tramadol HCL; Kardegic / 00002703 /; Primperan / 00041901 /; Primperan / 00041901 /; Tramadol HCL; Zelitrex / 01269701 /; Oxycontin; Oxygen; Ondansetron
Possible Dexamethasone side effects in
Reported by a physician from Germany on 2012-08-09
Patient:
Reactions: Dyspnoea, C-Reactive Protein Increased, General Physical Health Deterioration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-01-26
End date: 2012-07-18
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-01-26
End date: 2012-07-18
Possible Dexamethasone side effects in 32 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient: 32 year old female
Reactions: Dyspnoea, Maternal Exposure During Pregnancy, Throat Tightness, Off Label Use, Caesarean Section, Premature Delivery, Blood Pressure Decreased, Oxygen Saturation Decreased, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bupivacaine Hydrochloride W / Epinephrine
Dosage: 1.66 cc
Indication: Spinal Anaesthesia
Cefazolin
Indication: Prophylaxis
Cetirizine Hydrochloride
Indication: Mastocytosis
Cetirizine Hydrochloride
Indication: Prophylaxis
Dexamethasone
Indication: Prophylaxis
Diphenhydramine HCL
Indication: Prophylaxis
Fentanyl
Indication: Spinal Anaesthesia
Phenylephrine HCL
Indication: Caesarean Section
Sodium Citrate
Dosage: 30 cc
Administration route: Oral
Indication: Prophylaxis
Possible Dexamethasone side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: female
Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Left Ventricular Hypertrophy, Toxic Nodular Goitre, Nasal Congestion, Oesophageal Rupture, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Osteoporosis, Folliculitis, Fall, Gastric Ulcer, Haematemesis, Hyperparathyroidism, Chest Pain, Aortic Arteriosclerosis, Perineurial Cyst, Thyroid Mass, Depression, Decreased Appetite, Renal Failure Acute, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Syncope, Pulmonary Valve Incompetence, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Dysaesthesia, Gait Disturbance, Respiratory Tract Infection, Leukopenia, Vitamin D Deficiency, Weight Decreased, Goitre, Lower Limb Fracture, Herpes Zoster, Hypomagnesaemia, Uterine Leiomyoma, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Chest Discomfort, Stomatitis, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Sinusitis, RIB Fracture, Polyp, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Actos
Dosage: 30 mg, qhs
Indication: Diabetes Mellitus
Aredia
Dosage: 90 mg, qmo over 4 hrs
Indication: Multiple Myeloma
Start date: 2001-10-01
End date: 2002-01-01
Aredia
Start date: 2008-07-07
Dexamethasone
Zometa
Dosage: 4 mg, q2mo infusion over 25 mins every other month
Indication: Multiple Myeloma
End date: 2005-07-21
Other drugs received by patient: Cytoxan; Aspirin; Prednisone; Hepatitis B Vaccine; Velcade; Procrit / 00909301 /; Cyclophosphamide; Alkeran; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Pneumovax 23; Enalapril Maleate; Norvasc; Revlimid; Decadron Phosphate; Chemotherapeutics NOS; Vincristine + Adriamycin + Dexamethasone; Pentamidine; Potassium Chloride; Thalidomide; Polio-Vaccine; Melphalan Hydrochloride; Fortamet; Crestor; Magnesium Oxide; Xanax; Benadryl; Doxil; Avalide; Influenza Vaccine; Augmentin '125'; Metformin Hydrochloride
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in male
Reported by a physician from France on 2012-07-31
Patient: male
Reactions: Dyspnoea, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 900 mg, daily
Indication: Lung Neoplasm Malignant
Start date: 2012-03-05
End date: 2012-05-15
Cisplatin
Dosage: 140 mg, unk
Start date: 2012-03-05
End date: 2012-05-15
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Start date: 2012-03-04
End date: 2012-05-16
Emend
Dosage: 125 mg, unk
Administration route: Oral
Start date: 2012-03-03
End date: 2012-03-15
Folic Acid
Dosage: 0.4 mg, daily
Administration route: Oral
Start date: 2012-03-01
Lyrica
Dosage: 100 mg, bid
Methylprednisolone
Dosage: 120 mg, unk
Start date: 2012-03-05
End date: 2012-03-15
Ondansetron
Dosage: 8 mg, unk
Start date: 2012-03-03
End date: 2012-03-15
Oxycodone Hydrochloride
Dosage: 5 mg, prn
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Oxycontin
Dosage: 90 mg, daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zometa
Dosage: unk
Start date: 2012-05-15
End date: 2012-05-15
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31
Patient:
Reactions: Dyspnoea, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 900 mg, once
Start date: 2012-03-05
End date: 2012-03-05
Alimta
Dosage: 900 mg, once
Start date: 2012-03-27
End date: 2012-03-27
Alimta
Dosage: 900 mg, once
Start date: 2012-04-17
End date: 2012-04-17
Alimta
Dosage: 900 mg, once
Start date: 2012-05-15
End date: 2012-05-15
Cisplatin
Dosage: 140 mg, once
Start date: 2012-03-05
End date: 2012-03-05
Cisplatin
Dosage: 140 mg, once
Start date: 2012-05-15
End date: 2012-05-15
Cisplatin
Dosage: 140 mg, once
Start date: 2012-03-27
End date: 2012-03-27
Cisplatin
Dosage: 140 mg, once
Start date: 2012-04-17
End date: 2012-04-17
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Start date: 2012-03-04
End date: 2012-03-06
Dexamethasone
Dosage: 4 mg, bid
Start date: 2012-04-16
End date: 2012-04-16
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Start date: 2012-05-14
End date: 2012-05-16
Dexamethasone
Dosage: 4 mg, bid
Administration route: Oral
Start date: 2012-03-26
End date: 2012-03-28
Emend
Dosage: 125 mg, once
Administration route: Oral
Start date: 2012-05-15
End date: 2012-05-15
Emend
Dosage: 125 mg, once
Administration route: Oral
Start date: 2012-03-05
End date: 2012-03-05
Emend
Dosage: 125 mg, once
Administration route: Oral
Start date: 2012-03-27
End date: 2012-03-27
Emend
Dosage: 125 mg, once
Administration route: Oral
Start date: 2012-04-17
End date: 2012-04-17
Folic Acid
Dosage: 0.4 mg, qd
Administration route: Oral
Start date: 2012-02-27
End date: 2012-06-04
Lyrica
Dosage: 100 mg, bid
Administration route: Oral
Methylprednisolone
Dosage: 120 mg, once
Start date: 2012-04-17
End date: 2012-04-17
Methylprednisolone
Dosage: 120 mg, once
Start date: 2012-03-05
End date: 2012-03-05
Methylprednisolone
Dosage: 120 mg, once
Start date: 2012-05-15
End date: 2012-05-15
Methylprednisolone
Dosage: 120 mg, once
Start date: 2012-03-27
End date: 2012-03-27
Ondansetron
Dosage: 8 mg, once
Start date: 2012-05-15
End date: 2012-05-15
Ondansetron
Dosage: 8 mg, once
Start date: 2012-04-17
End date: 2012-04-17
Ondansetron
Dosage: 8 mg, once
Start date: 2012-03-27
End date: 2012-03-27
Ondansetron
Dosage: 8 mg, once
Start date: 2012-03-05
End date: 2012-03-05
Oxycontin
Dosage: 90 mg, qd
Administration route: Oral
Zometa
Dosage: unk
Start date: 2012-05-15
End date: 2012-05-15
Other drugs received by patient: Oxycodone HCL; Cyanocobalamin
Possible Dexamethasone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Velcade
End date: 2012-04-10
Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil
Possible Dexamethasone side effects in 63 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: 63 year old male
Reactions: Dyspnoea, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 900 mg, cyclic
Indication: Lung Adenocarcinoma
Start date: 2012-03-05
End date: 2012-05-15
Cisplatin
Dosage: 140 mg, cyclic
Indication: Lung Adenocarcinoma
Start date: 2012-03-05
End date: 2012-05-15
Dexamethasone
Dosage: 4 mg, 2x/day
Administration route: Oral
Start date: 2012-03-04
End date: 2012-05-16
Emend
Dosage: 125 mg, cyclic
Administration route: Oral
Start date: 2012-03-05
End date: 2012-05-15
Folic Acid
Dosage: 0.4 mg, 1x/day
Administration route: Oral
Start date: 2012-03-01
Lyrica
Dosage: 100 mg, 2x/day
Administration route: Oral
Methylprednisolone
Dosage: 120 mg, cyclic
Start date: 2012-03-05
End date: 2012-05-15
Ondansetron
Dosage: 8 mg, cyclic
Start date: 2012-03-05
End date: 2012-05-15
Oxycontin
Dosage: 40 mg in the morning and 50 mg in the evening
Administration route: Oral
Zometa
Dosage: unk
Start date: 2012-05-15
End date: 2012-05-15
Other drugs received by patient: Vitamin B-12; Oxyconorm
Possible Dexamethasone side effects in 78 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: 78 year old female, weighing 46.7 kg (102.7 pounds)
Reactions: Dyspnoea, Chest Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 32 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-03-23
Velcade
Dosage: 1.5 mg, unk
Indication: Multiple Myeloma
Start date: 2012-03-19
Other drugs received by patient: Methadone Hydrochloride; Fluconazole; Metoclopramide; Vantin / 01043502 /; Losartan Potassium; Senna / 00142201 /; Valtrex; Norvasc; Miralax; Prilosec; Dilaudid; Magnesium Oxide
Possible Dexamethasone side effects in female
Reported by a physician from France on 2012-07-25
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.82 milligram;
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Dexamethasone
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Rituximab
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Treanda
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Other drugs received by patient: Pegfilgrastim
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-24
Patient: male
Reactions: Dyspnoea, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 500 mg/m2, unk
Start date: 2012-05-15
Alimta
Dosage: 500 mg/m2, unk
Start date: 2012-03-27
Alimta
Dosage: 500 mg/m2, unk
Indication: Lung Adenocarcinoma
Start date: 2012-03-05
Alimta
Dosage: 500 mg/m2, unk
Start date: 2012-04-17
Cisplatin
Dosage: 75 mg/m2, unk
Start date: 2012-03-27
Cisplatin
Dosage: 75 mg/m2, unk
Start date: 2012-04-17
Cisplatin
Dosage: 75 mg/m2, unk
Start date: 2012-05-15
Cisplatin
Dosage: 75 mg/m2, unk
Indication: Lung Adenocarcinoma
Start date: 2012-03-05
Dexamethasone
Dosage: 4 mg, bid
Start date: 2012-04-04
End date: 2012-05-16
Emend
Dosage: 125 mg, daily
Administration route: Oral
Start date: 2012-03-27
Emend
Dosage: 125 mg, daily
Administration route: Oral
Start date: 2012-05-15
Emend
Dosage: 125 mg, daily
Administration route: Oral
Start date: 2012-03-05
Emend
Dosage: 125 mg, daily
Administration route: Oral
Start date: 2012-04-17
Folic Acid
Dosage: 0.4 mg, daily one week
Administration route: Oral
Start date: 2012-03-01
Lyrica
Dosage: 100 mg, bid
Administration route: Oral
Methylprednisolone
Dosage: 120 mg, unk
Start date: 2012-03-27
Methylprednisolone
Dosage: 120 mg, unk
Start date: 2012-04-17
Methylprednisolone
Dosage: 120 mg, unk
Start date: 2012-03-05
Methylprednisolone
Dosage: 120 mg, unk
Start date: 2012-05-15
Ondansetron
Dosage: 8 mg, daily
Oxycontin
Dosage: 90 mg, daily
Zometa
Start date: 2012-05-15
Other drugs received by patient: Oxycodone HCL; Vitamin B-12
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-24
Patient: male
Reactions: Dyspnoea, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alimta
Dosage: 500 mg/m2, unk
Start date: 2012-05-15
Alimta
Dosage: 500 mg/m2, unk
Indication: Lung Adenocarcinoma
Start date: 2012-03-05
Alimta
Dosage: 500 mg/m2, unk
Start date: 2012-03-27
Alimta
Dosage: 500 mg/m2, unk
Start date: 2012-04-17
Cisplatin
Dosage: 75 mg/m2, unk
Start date: 2012-05-15
Cisplatin
Dosage: 75 mg/m2, unk
Start date: 2012-04-17
Cisplatin
Dosage: 75 mg/m2, unk
Indication: Lung Adenocarcinoma
Start date: 2012-03-05
Cisplatin
Dosage: 75 mg/m2, unk
Start date: 2012-03-27
Dexamethasone
Dosage: 4 mg, bid
Start date: 2012-04-04
End date: 2012-05-16
Emend
Dosage: 125 mg, daily
Administration route: Oral
Start date: 2012-03-05
Emend
Dosage: 125 mg, daily
Administration route: Oral
Start date: 2012-03-27
Emend
Dosage: 125 mg, daily
Administration route: Oral
Start date: 2012-04-17
Emend
Dosage: 125 mg, daily
Administration route: Oral
Start date: 2012-05-15
Folic Acid
Dosage: 0.4 mg, daily one week
Administration route: Oral
Start date: 2012-03-01
Lyrica
Dosage: 100 mg, bid
Administration route: Oral
Methylprednisolone
Dosage: 120 mg, unk
Start date: 2012-03-05
Methylprednisolone
Dosage: 120 mg, unk
Start date: 2012-05-15
Methylprednisolone
Dosage: 120 mg, unk
Start date: 2012-04-17
Methylprednisolone
Dosage: 120 mg, unk
Start date: 2012-03-27
Ondansetron
Dosage: 8 mg, daily
Oxycontin
Dosage: 90 mg, daily
Zometa
Start date: 2012-05-15
Other drugs received by patient: Oxycodone HCL; Vitamin B-12
Possible Dexamethasone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore
Possible Dexamethasone side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male
Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-01-13
End date: 2012-02-03
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-10
End date: 2012-01-07
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-05-12
End date: 2011-05-25
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-01
Prednisolone
Dosage: 10 milligram
Indication: Multiple Myeloma
Start date: 2012-02-09
End date: 2012-02-17
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-13
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-03-30
Prednisolone
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2012-02-08
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-04-13
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2011-09-06
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-09-14
End date: 2011-10-03
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-22
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-31
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-01-25
End date: 2012-02-11
Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa
Possible Dexamethasone side effects in
Reported by a consumer/non-health professional from United States on 2012-07-16
Patient:
Reactions: Vomiting, Dyspnoea, Nausea, Pyrexia, Cardiomyopathy, Renal Failure Chronic, Weight Increased, Tumour Lysis Syndrome, Fatigue, Respiratory Failure, Vitamin B12 Deficiency, Alopecia, Ejection Fraction Decreased, Arteriosclerosis Coronary Artery, Respiratory Tract Infection, Cardiac Failure Congestive
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2007-11-05
End date: 2007-12-03
Other drugs received by patient: OS-CAL / 00108001 /; Colace; Nexium; Synthroid; Allopurinol; Lasix; Lisinopril; Lovenox; Aspirin
Possible Dexamethasone side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride
Possible Dexamethasone side effects in
Reported by a consumer/non-health professional from United States on 2012-07-09
Patient:
Reactions: Dyspnoea, Anaemia, General Physical Health Deterioration, Oesophageal Haemorrhage, Thrombocytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 8 mg, cyclic
Indication: Multiple Myeloma
Start date: 2010-08-30
End date: 2011-11-04
Doxorubicin HCL
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2011-08-30
End date: 2011-11-04
Velcade
Dosage: 1.3 mg, cyclic
Indication: Multiple Myeloma
Start date: 2011-08-30
End date: 2011-11-04
Other drugs received by patient: Moxonidin; Amlodipine; Finasterid Orion; Metoprolol Tartrate; Ramipril; Allopurinol; Levothyroxine Sodium; Calcivit D; Pantozol / 01263202 /; Hydromorphone HCL; Decostriol; Prednisone TAB; Tamsulosin HCL; Torsemide; Folsan
Possible Dexamethasone side effects in female
Reported by a physician from France on 2012-07-09
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.82 milligram;
Indication: Mantle Cell Lymphoma
Start date: 2012-02-02
Dexamethasone
Indication: Mantle Cell Lymphoma
Start date: 2012-02-29
Rituximab
Indication: Mantle Cell Lymphoma
Start date: 2012-02-29
Treanda
Indication: Mantle Cell Lymphoma
Start date: 2012-02-01
Other drugs received by patient: Pegfilgrastim
Possible Dexamethasone side effects in female
Reported by a lawyer from United States on 2012-07-02
Patient: female
Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Toxic Nodular Goitre, Left Ventricular Hypertrophy, Nasal Congestion, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Folliculitis, Fall, Gastric Ulcer, Hyperparathyroidism, Aortic Arteriosclerosis, Thyroid Mass, Perineurial Cyst, Depression, Renal Failure Acute, Decreased Appetite, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Pulmonary Valve Incompetence, Syncope, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Gait Disturbance, Dysaesthesia, Respiratory Tract Infection, Leukopenia, Weight Decreased, Vitamin D Deficiency, Goitre, Lower Limb Fracture, Herpes Zoster, Uterine Leiomyoma, Hypomagnesaemia, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Stomatitis, Chest Discomfort, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Sinusitis, RIB Fracture, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Actos
Dosage: 30 mg, qhs
Indication: Diabetes Mellitus
Aredia
Dosage: 90 mg, qmo over 4 hrs
Indication: Multiple Myeloma
Start date: 2001-10-01
End date: 2002-01-01
Aredia
Start date: 2008-07-07
Dexamethasone
Zometa
Dosage: 4 mg, q2mo infusion over 25 mins every other month
Indication: Multiple Myeloma
End date: 2005-07-21
Other drugs received by patient: Xanax; Procrit / 00909301 /; Pentamidine Isethionate; Crestor; Enalapril Maleate; Magnesium Oxide; Vincristine + Adriamycin + Dexamethasone; Aspirin; Augmentin '125'; Benadryl; Decadron; Thalidomide; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Avalide; Potassium Chloride; Influenza Vaccine; Melphalan Hydrochloride; Metformin HCL; Doxil; Alkeran; Fortamet; Chemotherapeutics NOS; Hepatitis B Vaccine; Cyclophosphamide; Cytoxan; Pneumovax 23; Polio-Vaccine; Revlimid; Velcade; Prednisone TAB; Norvasc
Possible Dexamethasone side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-07-02
Patient: 42 year old male
Reactions: Dyspnoea
Drug(s) suspected as cause:
Chirocaine
Indication: Analgesic Therapy
Dexamethasone
Dosage: 8 mg
Indication: Analgesic Therapy
Lidocaine
Dosage: 1% 5ml/hour
Lidocaine
Dosage: 1% 10ml/hour
Indication: Analgesic Therapy
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-06-28
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Vomiting, Stomatitis, Dyspnoea, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Respiratory Failure, Diarrhoea, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Rituximab
Dosage: on day 8 from cycle 3 to 7
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim
Possible Dexamethasone side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28
Patient: 48 year old female, weighing 31.8 kg (69.9 pounds)
Reactions: Dyspnoea, Chest Discomfort, Fatigue, Chest Pain, Sensation of Pressure
Drug(s) suspected as cause:
(Domperidone)
Dosage: 20 mg milligram(s), 1 day, oral ; 20 mg, as needed
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Chlorpheniramine Maleate
Dosage: 10 mg milligram(s) intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 4 mg milligram(s) oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 20 mg milligram(s), intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Granisetron
Dosage: 1 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Neulasta
Dosage: 6 mg milligram(s) subcutaneous
Indication: Chemotherapy
Paclitaxel
Dosage: see image
Indication: Breast Cancer
Start date: 2011-05-24
End date: 2011-07-05
Paclitaxel
Dosage: see image
Indication: Breast Cancer
End date: 2011-07-05
Ranitidine
Dosage: 50 mg milligram(s), intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: (Docusate); (Biotene / 00203502 / )
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-28
Patient: male, weighing 97.6 kg (214.7 pounds)
Reactions: Cellulitis, Dyspnoea, Hypotension, Localised Oedema, Circulatory Collapse, Muscular Weakness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alemtuzumab
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Start date: 2012-04-16
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2012-04-30
End date: 2012-05-24
Other drugs received by patient: Aspirin; Lansoprazole; Novorapid; Perindopril Erbumine; Simvastatin; Flucloxacillin; Allopurinol; Cotrim; Alendronate Sodium; Atenolol; Itraconazole; Lantus; Levothyroxine; Immune Globulin NOS; Acyclovir; Amitriptyline HCL
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-26
Patient: male, weighing 68.0 kg (149.7 pounds)
Reactions: Humerus Fracture, Small Intestinal Obstruction, Dyspnoea, Tendon Rupture, Sepsis, Urinary Retention
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Velcade
Dosage: 2.3 mg, cyclic
Indication: Multiple Myeloma
Start date: 2011-02-14
End date: 2011-02-24
Other drugs received by patient: Cymbalta; Percocet; Wellbutrin; Advair Diskus 100 / 50; Centrum Silver / 01292501 /; Clonazepam; Calcium with Vitamin D / 00944201 /; Nexium; Aspirin; Lunesta; Magnesium Sulfate; Crestor; Oxycontin; Senna / 00142201 /; Proventil / 00139501 /
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25
Patient:
Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Stomatitis, Vomiting, Dyspnoea, Nausea, Gastrointestinal Toxicity, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Lymphoma
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: days 1-5 during cycle 3,5 and 7
Cyclophosphamide
Dosage: for 5 days in cycle 1
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Cytarabine
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Dexamethasone
Dosage: on days 1-5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Dexamethasone
Dosage: on days 1-5 of cycle 2,4 and 6
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Doxorubicin HCL
Dosage: on days 4 and 5 of cycle 3,5 and 7
Indication: Burkitt's Leukaemia
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Etoposide
Dosage: on days 4 and 5 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Lymphoma
Ifosfamide
Dosage: on days 1-5 in cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Methotrexate
Dosage: on day 1 of cycle 2,4 and 6
Methotrexate
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Lymphoma
Prednisone TAB
Dosage: for 7 days in cycle 1
Indication: Burkitt's Leukaemia
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: on day 8 from cycle 3 to 7
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Leukaemia
Rituximab
Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
Indication: Burkitt's Lymphoma
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Indication: Burkitt's Leukaemia
Vincristine
Dosage: on day 1 of cycle 2,4 and 6
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Vincristine
Dosage: on day 1 of cycle 3,5 and 7
Indication: Burkitt's Lymphoma
Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim
Page 1 Next >>
|
